🔎 Trials Near Me

Beranda › Kanker Endometrium › Indiana › Indianapolis

Uji klinis Kanker Endometrium di Indianapolis, IN

14 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Indianapolis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Menerima pesertaFase 3
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 5 Okt 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Menerima pesertaFase 2
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Saint Catherine Hospital, Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT05112601

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Menerima pesertaFase 2
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • Community Health Network, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Menerima pesertaFase 1
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Usia 15 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Menerima pesertaFase 1/2
  • Riley Hospital for Children, Indianapolis
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Menerima pesertaFase 2
  • Ascension St. Vicent Hospital, Inc., Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 21 Agu 2026 · NCT05548296

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Menerima pesertaFase 1
  • Indiana University, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07306559

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Community Health Network, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Menerima pesertaFase 3
  • Research Site, Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336

A Study of LY4175408 in Participants With Advanced Cancer

Menerima pesertaFase 1
  • Community Health Network, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07046923

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Menerima pesertaFase 1/2
  • Community Health Network, Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT05902988

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Menerima pesertaFase 1/2
  • Community Health Network, Inc., Indianapolis
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2025 · NCT05669430

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Menerima pesertaFase 2/3
  • Indiana University, Indianapolis
Usia 18 ke atas · Wanita · Diperbarui 2 Mei 2024 · NCT05797831

Uji klinis Kanker Endometrium di kota lain

Studi lain di Indianapolis

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.